Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W
Department of Neurology, University of Heidelberg, Germany.
Stroke. 1998 Aug;29(8):1550-5. doi: 10.1161/01.str.29.8.1550.
The purpose of this study was to prospectively evaluate a protocol with hypertonic saline hydroxyethyl starch (HS-HES) and mannitol in stroke patients with increased intracranial pressure (ICP).
We studied 30 episodes of ICP crisis in 9 patients. ICP crisis was defined as (1) a rise of ICP of more than 25 mm Hg (n = 22), or (2) pupillary abnormality (n=3), or (3) a combination of both (n=5). Baseline treatment was performed according to a standardized protocol. For initial treatment, the patients were randomly assigned to either infusion of 100 mL HS-HES or 40 g mannitol over 15 minutes. For repeated treatments the 2 substances were alternated. ICP, blood pressure, and cerebral perfusion pressure (CPP) were monitored over 4 hours. Blood gases, hematocrit, blood osmolarity, and sodium were measured before and 15 and 60 minutes after the start of infusion. Treatment was regarded as effective if ICP decreased >10% below baseline value or if the pupillary reaction had normalized.
Treatment was effective in all 16 HS-HES-treated and in 10 of 14 mannitol-treated episodes. ICP decreased from baseline values in both groups, P < 0.01. The maximum ICP decrease was 11.4 mm Hg (after 25 minutes) in the HS-HES-treated group and 6.4 mm Hg (after 45 minutes) in the mannitol-treated group. There was no constant effect on CPP in the HS-HES-treated group, whereas CPP rose significantly in the mannitol-treated group. Blood osmolarity rose by 6.2 mmol/L in the mannitol-treated group and by 10.5 mmol/L in the HS-HES-treated group; sodium fell by 3.2 mmol/L in the mannitol and rose by 4.1 mmol/L in the HS-HES-treated group.
Infusion of 40 g mannitol and 100 mL HS-HES decreases increased ICP after stroke. The maximum effect occurs after the end of infusion and is visible over 4 hours. HS-HES seems to lower ICP more effectively but does not increase CPP as much as does mannitol.
本研究旨在前瞻性评估高渗盐水羟乙基淀粉(HS-HES)和甘露醇联合方案对颅内压(ICP)升高的卒中患者的疗效。
我们对9例患者的30次ICP危机发作进行了研究。ICP危机定义为:(1)ICP升高超过25 mmHg(n = 22);(2)瞳孔异常(n = 3);或(3)两者兼具(n = 5)。基线治疗按照标准化方案进行。初始治疗时,患者被随机分配在15分钟内输注100 mL HS-HES或40 g甘露醇。重复治疗时,两种药物交替使用。在4小时内监测ICP、血压和脑灌注压(CPP)。在输注开始前、开始后15分钟和60分钟测量血气、血细胞比容、血渗透压和钠浓度。如果ICP下降至基线值以下>10%或瞳孔反应恢复正常,则认为治疗有效。
16次接受HS-HES治疗的发作和14次接受甘露醇治疗的发作中有10次治疗有效。两组的ICP均较基线值下降,P < 0.01。HS-HES治疗组ICP最大下降幅度为11.4 mmHg(25分钟后),甘露醇治疗组为6.4 mmHg(45分钟后)。HS-HES治疗组对CPP无持续影响,而甘露醇治疗组CPP显著升高。甘露醇治疗组血渗透压升高6.2 mmol/L,HS-HES治疗组升高10.5 mmol/L;甘露醇治疗组钠浓度下降3.2 mmol/L,HS-HES治疗组升高4.1 mmol/L。
输注40 g甘露醇和100 mL HS-HES可降低卒中后升高的ICP。最大效应在输注结束后出现,并在4小时内可见。HS-HES似乎能更有效地降低ICP,但对CPP的升高幅度不如甘露醇。